BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $259,045 | +12.5% | 5,686 | +0.2% | 0.06% | +7.8% |
| Q1 2023 | $230,268 | -20.3% | 5,677 | +0.1% | 0.05% | -23.9% |
| Q4 2022 | $289,026 | -5.2% | 5,671 | +0.1% | 0.07% | -11.8% |
| Q3 2022 | $305,000 | -16.0% | 5,664 | +0.1% | 0.08% | -6.2% |
| Q2 2022 | $363,000 | +3.1% | 5,659 | +24.8% | 0.08% | +24.6% |
| Q1 2022 | $352,000 | -9.5% | 4,536 | 0.0% | 0.06% | 0.0% |
| Q4 2021 | $389,000 | +6.6% | 4,536 | 0.0% | 0.06% | +1.6% |
| Q3 2021 | $365,000 | 0.0% | 4,536 | 0.0% | 0.06% | 0.0% |
| Q2 2021 | $365,000 | +29.0% | 4,536 | +35.1% | 0.06% | +16.4% |
| Q1 2021 | $283,000 | +5.2% | 3,358 | 0.0% | 0.06% | +1.9% |
| Q4 2020 | $269,000 | -0.4% | 3,358 | 0.0% | 0.05% | -11.5% |
| Q3 2020 | $270,000 | -6.6% | 3,358 | 0.0% | 0.06% | -14.1% |
| Q2 2020 | $289,000 | +5.9% | 3,358 | 0.0% | 0.07% | -17.4% |
| Q1 2020 | $273,000 | -10.8% | 3,358 | -8.2% | 0.09% | +10.3% |
| Q4 2019 | $306,000 | -4.4% | 3,658 | 0.0% | 0.08% | -17.0% |
| Q3 2019 | $320,000 | +6.7% | 3,658 | 0.0% | 0.09% | +13.3% |
| Q2 2019 | $300,000 | +1.0% | 3,658 | 0.0% | 0.08% | -2.4% |
| Q1 2019 | $297,000 | +23.8% | 3,658 | +0.0% | 0.08% | +1.2% |
| Q4 2018 | $240,000 | -14.9% | 3,657 | -0.0% | 0.08% | +23.5% |
| Q3 2018 | $282,000 | +4.4% | 3,658 | +0.0% | 0.07% | -12.8% |
| Q2 2018 | $270,000 | +13.9% | 3,657 | 0.0% | 0.08% | +9.9% |
| Q1 2018 | $237,000 | +0.4% | 3,657 | -0.0% | 0.07% | -9.0% |
| Q4 2017 | $236,000 | +2.6% | 3,658 | 0.0% | 0.08% | 0.0% |
| Q3 2017 | $230,000 | +4.1% | 3,658 | 0.0% | 0.08% | +9.9% |
| Q2 2017 | $221,000 | -11.6% | 3,658 | +2.2% | 0.07% | -23.7% |
| Q2 2015 | $250,000 | +2.0% | 3,580 | 0.0% | 0.09% | +3.3% |
| Q1 2015 | $245,000 | -16.1% | 3,580 | -10.1% | 0.09% | -17.4% |
| Q4 2014 | $292,000 | +2.1% | 3,980 | 0.0% | 0.11% | +0.9% |
| Q3 2014 | $286,000 | -0.7% | 3,980 | 0.0% | 0.11% | -3.6% |
| Q2 2014 | $288,000 | -99.9% | 3,980 | -15.0% | 0.11% | -23.3% |
| Q1 2014 | $344,354,000 | +105855.1% | 4,680 | 0.0% | 0.15% | +6.6% |
| Q4 2013 | $325,000 | +5.9% | 4,680 | 0.0% | 0.14% | -4.9% |
| Q3 2013 | $307,000 | -6.1% | 4,680 | -1.0% | 0.14% | -18.6% |
| Q2 2013 | $327,000 | – | 4,725 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |